Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Closing The Spread: 340B Providers Face Sharp Cuts Under Medicare Proposal

Executive Summary

Medicare payments to hospitals for drugs provided under the 340B program would be reduced to average sales price (ASP) minus 22.5%, which CMS believes is more closely aligned with the discounted price obtained by the providers.


Related Content

Medicare Lowers Payments For 340B Drugs: Promising Sign For Further Reform?
Could Medicare 340B Payment Cuts Lead Hospitals To Buy At List Price?
CMS Proposal On Part D May Address Drug Costs, But Will It Target Prices?
Medicare Part D Premiums Dip As Rebates Grow Faster Than Drug Costs To Plans
340B Reforms: Oversight Hearing Suggests Slow, Piecemeal Approach
340B Needs Legislative Fix For Overspending On Medicare Patients, GAO Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts